Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

abrysvo × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 551 Specimen Handling 543 Magnetic Resonance Spectroscopy 449 Carboplatin 357 Cyclophosphamide 336 Biopsy 316 Cisplatin 300 Paclitaxel 267 Nivolumab 259 Radiotherapy 240 Gemcitabine 233 Bevacizumab 198 Dexamethasone 192 fludarabine 183 venetoclax 179 Docetaxel 161 Oxaliplatin 160 atezolizumab 157 durvalumab 156 Fluorouracil 155 Rituximab 149 Pemetrexed 145 Capecitabine 145 Doxorubicin 135 Radiation 132 Standard of Care 129 Lenalidomide 128 Drug Therapy 126 Prednisone 125 Radiosurgery 122

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05170399 2026-02-05

Vaccine Responses in Patients With B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 4 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡